Scholarly article on Androst-16-en-3-one 32925-78-3 from Journal of Agricultural and Food Chemistry p. 1241,1242,1243

DOI: 10.1021/jf60214a033

Source and publish data:

Journal of Agricultural and Food Chemistry p. 1241,1242,1243 (1977)

Update date:2022-08-05

Topics:

Authors:

Thompson

Pearson Pearson

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jf60214a033

Full text of DOI:10.1021/jf60214a033

Products guided by the article

Product name:Androst-16-en-3-one

Cas No:32925-78-3

R&D Labs maybe for 32925-78-3

Tianjin Chemsyntech Chemical Co., Ltd

Contact:+86-22-60872258

Address:Haitai green industry base in Tianjin, K1,5-601
suzhou chukai pharmateach co,.ltd

Contact:86-512-88812511

Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
NIGNXIA XINDACHANG TECHNOLOGY CO.,LTD

Contact:86-0951-7815345

Address:North side of Qiyuan Road, west side of Yuanfeng Highway, New Material Park, Ningdong Energy and Chemical Industry Base, Ningxia,China
Changzhou Screw International Trading Co., Ltd.

Contact:13906149256,18001495888

Address:Jiangsu，Jintanqu
Qingdao Kylin Trading Co., Ltd.

Contact:0086-532-68979884/58972912/68972263/65/88171519

Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.

Relevant to this article

Doi:10.1007/BF00567852
()
Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds

Doi:10.1002/ardp.201800123
(2018)
Synthesis of a Tri-, a Penta-, and a Hepta-saccharide Containing Terminal N-Acetyl-β-D-lactosaminyl Residues, Part of the 'Complex-type' Carbohydrate Moiety of Glycoproteins

Doi:10.1039/P19810002070
(1981)
Independent generation and characterization of a C2′-oxidized abasic site in chemically synthesized oligonucleotides

Doi:10.1021/jo049033d
(2004)
Thermolysis of dimethyl 3,3-(2,2′-biphenylyl)-3H-pyrazole-4,5-dicarboxylate

Doi:10.1021/jo00322a042
(1981)
Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation.

Doi:10.1021/jm049752k
(2004)

Article Doi

DOI: 10.1021/jf60214a033